203 related articles for article (PubMed ID: 30260376)
1. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
Soto J; Soto P; Ajata A; Luque C; Tintaya C; Paz D; Rivero D; Berman J
Clin Infect Dis; 2019 Feb; 68(5):844-849. PubMed ID: 30260376
[TBL] [Abstract][Full Text] [Related]
2. Miltefosine Combined with Intralesional Pentamidine for
Soto J; Soto P; Ajata A; Rivero D; Luque C; Tintaya C; Berman J
Am J Trop Med Hyg; 2018 Nov; 99(5):1153-1155. PubMed ID: 30255833
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous leishmaniasis treatment.
Minodier P; Parola P
Travel Med Infect Dis; 2007 May; 5(3):150-8. PubMed ID: 17448941
[TBL] [Abstract][Full Text] [Related]
4. Treatment of New World cutaneous and mucosal leishmaniases.
Berman JD
Clin Dermatol; 1996; 14(5):519-22. PubMed ID: 8889330
[TBL] [Abstract][Full Text] [Related]
5. Topical paromomycin for New World cutaneous leishmaniasis.
Sosa N; Pascale JM; Jiménez AI; Norwood JA; Kreishman-Detrick M; Weina PJ; Lawrence K; McCarthy WF; Adams RC; Scott C; Ransom J; Tang D; Grogl M
PLoS Negl Trop Dis; 2019 May; 13(5):e0007253. PubMed ID: 31048871
[TBL] [Abstract][Full Text] [Related]
6. Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.
Soto J; Rojas E; Guzman M; Verduguez A; Nena W; Maldonado M; Cruz M; Gracia L; Villarroel D; Alavi I; Toledo J; Berman J
Clin Infect Dis; 2013 May; 56(9):1255-60. PubMed ID: 23390069
[TBL] [Abstract][Full Text] [Related]
7. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
de Morais-Teixeira E; Aguiar MG; Soares de Souza Lima B; Ferreira LA; Rabello A
J Antimicrob Chemother; 2015 Dec; 70(12):3283-90. PubMed ID: 26346991
[TBL] [Abstract][Full Text] [Related]
8. Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers.
Mouri O; Melenotte C; Guéry R; Cotteret C; Schweitzer-Chaput A; Perignon A; Thellier M; Bourrat E; Kaguelidou F; Siriez JY; Malvy D; Gangneux JP; Duvignaud A; Ravel C; Cisternino S; Ransom J; Caumes E; Lortholary O; Grogl M; Buffet P
PLoS Negl Trop Dis; 2023 Aug; 17(8):e0011492. PubMed ID: 37561802
[TBL] [Abstract][Full Text] [Related]
9. Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials.
Kim DH; Chung HJ; Bleys J; Ghohestani RF
PLoS Negl Trop Dis; 2009; 3(2):e381. PubMed ID: 19221595
[TBL] [Abstract][Full Text] [Related]
10. Topical paromomycin with or without gentamicin for cutaneous leishmaniasis.
Ben Salah A; Ben Messaoud N; Guedri E; Zaatour A; Ben Alaya N; Bettaieb J; Gharbi A; Belhadj Hamida N; Boukthir A; Chlif S; Abdelhamid K; El Ahmadi Z; Louzir H; Mokni M; Morizot G; Buffet P; Smith PL; Kopydlowski KM; Kreishman-Deitrick M; Smith KS; Nielsen CJ; Ullman DR; Norwood JA; Thorne GD; McCarthy WF; Adams RC; Rice RM; Tang D; Berman J; Ransom J; Magill AJ; Grogl M
N Engl J Med; 2013 Feb; 368(6):524-32. PubMed ID: 23388004
[TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
Chacko A; Joseph M; Feltis T; Morris SK
Am J Trop Med Hyg; 2016 Oct; 95(4):793-794. PubMed ID: 27549634
[TBL] [Abstract][Full Text] [Related]
12. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
Grogl M; Schuster BG; Ellis WY; Berman JD
J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
Mussi SV; Fernandes AP; Ferreira LA
Parasitol Res; 2007 May; 100(6):1221-6. PubMed ID: 17206508
[TBL] [Abstract][Full Text] [Related]
14. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.
Asilian A; Davami M
Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cutaneous leishmaniasis with 20% paromomycin ointment.
Stanimirović A; Stipić T; Skerlev M; Basta-Juzbasić A
J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):214-7. PubMed ID: 10642059
[TBL] [Abstract][Full Text] [Related]
16. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study.
Soto J; Fuya P; Herrera R; Berman J
Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509
[TBL] [Abstract][Full Text] [Related]
17. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
Moosavi Z; Nakhli A; Rassaii S
Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
[No Abstract] [Full Text] [Related]
18. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
Shazad B; Abbaszadeh B; Khamesipour A
Eur J Dermatol; 2005; 15(2):85-7. PubMed ID: 15757817
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of New World cutaneous leishmaniasis with a combination of topical paromomycin/methylbenzethonium chloride and injectable meglumine antimonate.
Soto J; Hernandez N; Mejia H; Grogl M; Berman J
Clin Infect Dis; 1995 Jan; 20(1):47-51. PubMed ID: 7727669
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
Faghihi G; Tavakoli-kia R
Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
